Vimarsana
Biggest News Aggregation in the World

Spiro Rombotis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spiro Rombotis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spiro Rombotis Today - Breaking & Trending Today

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024 - Vimarsana News

Cyclacel Pharmaceuticals to Present at Biotech Showcase 2024

02.01.2024 - BERKELEY HEIGHTS, N.J., Jan. 02, 2024 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company'), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announced ...

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcript - Vimarsana News

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals Third Quarter 2023 Results Conference Call and Webcast. [Operator Instructions] Please note, today's call is being recorded.

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcript - Vimarsana News

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2023 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022 - Vimarsana News

Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022

26.10.2022 - Daily dosing of fadraciclib was well tolerated; single agent activity observed across multiple tumor types including 2 PRs in T-cell lymphoma patientsBERKELEY HEIGHTS, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: ... Seite 1

Smaller biotechs making big advances - Vimarsana News

Smaller biotechs making big advances

Smaller biotech companies are also making some big advances and contributions in the fight against cancer.

Source: njbiz.com